Having trouble accessing articles? Reset your cache.

Igdrasol, Sorrento deal

Sorrento gained an exclusive option to acquire Igdrasol in a stock deal. Upon exercise, Sorrento will issue 76.2 million shares of its common stock

Read the full 240 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE